NOD2 and systemic lupus erythematosus: Consistent to the previous finding, upon stimulation with NOD2 agonist, our data showed an observable increased relative induction (%) of IL-1β upon MDP stimulation in SLE patients (Groups 1 and 3) compared to controls.